ViennaLab Diagnostics GmbH

Modern cancer therapy requires detection of specific variants in cancer-associated genes. ViennaLab Diagnostics offers highly sensitive assays to optimize cancer therapy.

Somatic pathogenic variants in BRAF, EGFR, KRAS and NRAS genes may influence cancer therapies. The identification of such pathogenic variants in these genes allows targeted treatment and stratification of cancer patients.
Genetic variants of genes involved in drug metabolism (e.g. DPYD and TPMT) can significantly alter the response to chemotherapeutic treatment.
The impact of specific genetic variants are covered in current guidelines for the respective type of cancer.

Articles
Title
BRAF
EGFR & EGFR T790M
FCGR
Hereditary Cancer NGS Assay
KRAS & NRAS
PGX-5FU XL
PGX-TPMT
Somatic Mutations NGS Assay

We use Matomo to analyze the access to our website. We pass on information about your use of our website to our partners for analysis. Our partners may combine this information with other data that you have provided to them or that they have collected as part of your use of the services. I agree.

Deny Allow